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In this study, we showed that Mycobacterium abscessus 
MAB2560 induces the maturation of dendritic cells (DCs), 
which are representative antigen-presenting cells (APCs). M. 
abscessus MAB2560 stimulate the production of pro-inflamma-
tory cytokines [interleukin (IL)-6, tumor necrosis factor (TNF)-α, 
IL-1β, and IL-12p70] and reduce the endocytic capacity and 
maturation of DCs. Using TLR4-/- DCs, we found that MAB2560 
mediated DC maturation via Toll-like receptor 4 (TLR4). 
MAB2560 also activated the MAPK signaling pathway, which 
was essential for DC maturation. Furthermore, MAB2560- 
treated DCs induced the transformation of naïve T cells to 
polarized CD4+ and CD8+ T cells, which would be crucial for 
Th1 polarization of the immune response. Taken together, our 
results indicate that MAB2560 could potentially regulate the 
host immune response to M. abscessus and may have critical 
implications for the manipulation of DC functions for 
developing DC-based immunotherapy. [BMB Reports 2014; 
47(9): 512-517]
INTRODUCTION
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) 
that play major roles in innate and adaptive immune responses 
(1). DCs express a variety of co-stimulatory surface molecules 
and MHC class I and II, and are classified into immature DCs 
and mature DCs according to their phenotype. Immature DCs 
capture and internalize pathogens via pattern recognition re-
ceptors (PRRs) (2). 
　Nontuberculous mycobacteria (NTM) are ubiquitously dis-
tributed in the environment (3) and cause a wide spectrum of 
human infections, such as skin and soft tissue infections, lung 
infections, and opportunistic infections (4), in immunocompro-
mised patients such as the HIV-infected individuals (5). 
Mycobacterium abscessus infections present a therapeutic 
challenge because M. abscessus strains are resistant to most 
antibiotics and linked to high death rate (6). APC-mediated in-
nate and adaptive immune responses are crucial in the pro-
tection against M. abscessus infections (7). 
　Synthetic agonists of TLR3, TLR4, TLR5, TLR7, TLR8, and 
TLR9 have been recently identified as suitable im-
munostimulants of APCs (8). Moreover, on the basis of the effi-
cacy of TLR agonists used thus far, the use of TLR ligands as 
adjuvants in humans is likely to be developed in the future. 
Therefore, DC maturation and activation by various microbial 
through TLRs signaling is the decisive link between innate and 
adaptive immune responses and is pivotal to the generation of 
protective immunity.
　Recently, Shin et al. have shown that M. abscessus induces 
the activation of Raw264.7, a macrophage cell line, through 
TLR2 (7). Several ligands of TLR2 and TLR4 from mycobacteria 
have been discovered including LpqH (9), LprA (10), LprG 
(11), lipomannan (12), certain lipoarabinomannan (LAM) spe-
cies (13), phosphatidyl-myo-inositol mannoside (14), PE_PGRS 
(15), HBHA (16), and CobT (17). Most of the identified ligands 
of TLR2 were purified from M. tuberculosis; however, little is 
known about the ligands purified from M. abscessus. 
MAB2560 consists of 201 amino acids and is the hypothetical 
protein of M. abscessus. However, there is still little in-
formation on MAB2560, and its function in M. abscessus re-
mains unknown.
　Taken together, our results suggest that MAB2560 is an ef-
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Fig. 1. MAB2560 induces the maturation of DCs. Immature DCs 
were treated with MAB2560 (2.5 μg/ml) or LPS (50 ng/ml) for 24 
h. (A) The expression of surface markers was analyzed by flow 
cytometry stained with anti-CD80, anti-CD86, anti-MHC class I, or 
anti-MHC class II in CD11c+ gated cells. The percentages are in-
dicated in the histogram. Results are representative of three experi-
ments with similar data. (B) ELISA was performed to determine the 
levels of IL-6, TNF-α, IL-1β, IL-12p70, and IL-10 in MAB2560- or 
LPS-treated DCs. Data are means and SEM of 3 experiments. **P 
＜ 0.01 and ***P ＜ 0.001 compared to medium control. (C) The 
endocytic capacity of DCs using FITC-conjugated dextran uptake 
systems was assessed at 37oC and 4oC (as a negative control) by 
flow cytometric analysis. The percentage of FITC-dextran in 
CD11c+ cells is indicated in the dot plot diagram. Results are rep-
resentative of three experiments with similar data. 
fective Th1 polarizing adjuvant and that immune stimulation 
appears to be mediated through activation of DCs by 
TLR4-mediated MAPKs pathways. 
RESULTS
MAB2560 is nontoxic to DCs and enhances DC maturation
To examine the immunological effect of MAB2560 on DCs, 
we purified soluble recombinant MAB2560 using the 
Escherichia coli expression system under endotoxin-free ex-
perimental conditions. Using the LAL endotoxin assay kit 
(GenScript USA, Inc., Piscataway, NJ, USA), we confirmed that 
endotoxin contamination of MAB2560 had not occurred (＜15 
pg/ml). As shown in Supplementary Fig. 1A, we detected a pu-
rified band of MAB2560 in the range of 21 kDa. Next, we in-
vestigated the cytotoxicity of MAB2560 against DCs using 
Annexin V and propidium iodide (PI) staining. We observed 
no marked change in the percentage of dead cells in DCs 
stimulated with MAB2560 (up to 2.5 μg/ml concentration) 
(Supplementary Fig. 1B). Thus, MAB2560 had no effect on cell 
death. Furthermore, proteinase K- or heat-treated MAB2560 
lost its activity to enhance the levels of CD86 in DCs. 
However, MAB2560 was resistant to polymyxin B treatment, 
indicating that LPS contamination was not responsible for the 
observed effects (Supplementary Fig. 1).
　To investigate the effect of MAB2560 on the maturation of 
DCs, we evaluated the co-stimulatory molecules and MHC 
classes, which are involved in T cell activation. Fig. 1A shows 
that MAB2560-treated DCs had increased levels of CD80, 
CD86, and MHC class I and II. LPS, which is a well-known ac-
tivator of DC maturation, served as a positive control. Next, 
we measured the production of pro- and anti-inflammatory cy-
tokines in MAB2560-treated DCs. Fig. 1B shows that TNF-α, 
IL-1β, and IL-6 levels significantly increased in MAB2560-treat-
ed DCs. whereas the secretion of IL-12, which drives Th1 po-
larization, was significantly enhanced in MAB2560-treated 
DCs, and the production of IL-10, which inhibits the function 
of Th1 immune responses, was not significantly enhanced. 
Generally, immature DCs have a higher antigen endocytic ca-
pacity than mature DCs. Therefore, we examined the influence 
of MAB2560 on the endocytic capacity of DCs, using the dex-
tran-FITC uptake experiment. MAB2560-treated DCs had di-
minished endocytic capacity, as expected for mature DCs (Fig. 
1C). On the basis of these results, we inferred that MAB2560 is 
a potent inducer of DC maturation.
TLR4 is required for the MAB2560-induced maturation of DCs
We investigated whether MAB2560 acts through TLRs in DCs. 
To test the ability of MAB2560 to activate DCs via TLRs, we 
measured the expression of surface molecules and the pro-
duction of pro-inflammatory cytokines, such as TNF-α and 
IL-6, in MAB2560-treated WT, TLR2-/-, and TLR4-/- DCs. 
MAB2560 increased the expression of surface molecules (Fig. 
2A) and the production of pro-inflammatory cytokines (Fig. 2B) 
in WT and TLR2-/- DCs. On the other hand, these effects were 
strongly decreased in TLR4-/- DCs, indicating that MAB2560 is 
a potent agonist of DC maturation that acts through a 
TLR4-depedent mechanism. Next, we asked whether 
MAB2560 could bind to TLR4. Thus, we analyzed the inter-
action between MAB2560 and TLR4 using the BLItz system. 
His-tagged recombinant TLR4/MD2 was labeled with an an-
ti-penta-HIS biosensor. Association was started by dipping the 
TLR4-tagged HIS sensor in buffers of Pam3CSK4, LPS, 
MAB2560, or PBS (Supplementary Fig. 3A). MAB2560 bound 
to TLR4 in a dose-dependent manner, and the concen-
tration-binding rate curve between TLR4 and MAB2560 was 
calculated (Supplementary Fig. 3B). Dissociation was started 
by dipping the biosensor into PBS. The calculated values of 
Ka, Kd, and KD between MAB2560 and TLR4/MD2 were 
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Fig. 2. MAB2560 induces the maturation of DCs via TLR4. DCs 
derived from WT, TLR2-/-, or TLR4-/- mice were treated with 
MAB2560 (2.5 μg/ml) or LPS (50 ng/ml) for 24 h. (A) Histograms 
show the expression of CD80, CD86, MHC class I, or MHC class 
II in CD11c+-gated cells. The percentages are indicated in the 
histogram. Results are representative of three experiments with 
similar data. (B) ELISA was performed to determine the levels of 
IL-6 and TNF-α in MAB2560- or LPS-treated DCs. Data are means 
and SEM of 3 experiments. 
Fig. 3. The activation of DCs by MAB2560 enhances the pro-
liferation of CD8+ and CD4+ T-cells. (A) OVA257-264-specific CD8+
T cells were isolated, stained with CFSE, and then co-cultured 
with immature DCs, OVA257-264-pulsed DCs, OVA257-264-pulsed 
MAB2560-treated DCs, or OVA257-264-pulsed LPS-treated DCs for 
72 h. Histograms showing CD8+ T-cell proliferation as assessed 
by flow cytometry. Results are representative of three experiments 
with similar data. (B) OVA323-339-specific CD4+ T cells were iso-
lated, stained with CFSE, and then co-cultured with immature 
DCs, OVA323-339-pulsed DCs, OVA323-339-pulsed MAB2560-treated 
DCs, or OVA323-339-pulsed LPS-treated DCs for 72 h. Histograms 
showing CD8+ T-cell proliferation as assessed by flow cytometry. 
Results are representative of three experiments with similar data. 
(C) The production of IFN-γ was measured in each culture super-
natant from (A) and (B) at 72 h by ELISA. 
1.738e6 (1/Ms), 2.281e-2 (1/S), and 1.31 nM, respectively. 
These results indicated that the MAB2560-mediated DC matu-
ration occurred through binding to the TLR-4, rather than the 
TLR-2, signaling cascade.
MAB2560-treated DCs induce the proliferation of CD8+ and 
CD4+ T-cells
Generally, T cells are stimulated by antigens presented by ma-
ture DCs. Naïve T cells are then induced to proliferate and dif-
ferentiate into effector or helper T cells. To confirm whether 
MAB2560-treated DCs induce T-cell proliferation, we per-
formed a mixed lymphocyte reaction (MLR) assay using OT-I T 
cell receptor (TCR) transgenic CD8+ T cells and OT-II TCR 
transgenic CD4+ T cells, which express a TCR specific for the 
MHC class I-restricted OVA peptide 257-264 Ag (OVA257-264) 
and the MHC class II-restricted OVA peptide 323-339 Ag 
(OVA323-339) in DCs, respectively. MAB2560 treatment en-
hanced the proliferation of CD8+ and CD4+ T-cells, similar to 
the LPS-treated group (positive control) (Fig. 3A). These results 
demonstrate that MAB2560 is a potent stimulus for the pro-
liferation of CD8+ and CD4+ T cells via DC activation. In ad-
dition, we investigated IFN-γ production under MLR 
conditions. A higher level of IFN-γ produced by T-cells primed 
with MAB2560-treated DCs (Fig. 3B), indicating that matured 
DCs stimulated by MAB2560 directly drive naïve T cell polar-
ization toward a Th1 phenotype. 
MAPKs are involved in the maturation of DCs
MAPK signaling pathways play a pivotal role in DC maturation 
(18). Thus, we investigated whether MAB2560 influences 
MAPKs activation in DCs. MAB2560 activated MAPK path-
ways, such as p38 MAPK, JNK, and ERK1/2 (Fig. 4). 
Furthermore, we tested whether MAPK inhibitors specifically 
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Fig. 4. MAB2560 activates MAPKs in DCs. For MAPK activation 
analysis, DCs were treated with MAB2560 (2.5 μg/ml) for 0, 5, 
15, 30, 45, and 60 min. Cell lysates were prepared and immuno-
blotted with antibodies against p-p38 MAPK, p-JNK, p-ERK1/2, 
and α-tubulin. Results are representative of three experiments with 
similar data. 
suppresses the MAB2560-induced activation of MAPKs. We 
found that specific inhibitors of MAPKs specifically inhibited 
the MAB2560-induced activation of MAPKs (Supplementary 
Fig. 4). These results showed that MAB2560 activates the 
MAPK signaling pathway, and we inferred that DC maturation 
is through the activation of the above-mentioned signaling 
cascade.
DISCUSSION
In this study, MAB2560 was purified and identified from an M. 
abscessus strain in our group for the first time; however, the 
function of MAB2560 in immune systems has not been studied 
yet. The recognition of TLRs by various stimuli in DCs is crit-
ical for the switch from an immature to a mature phenotype 
for the leading the effective systemic immune responses. M. 
abscessus has been recently suggested induce the activation of 
APCs (7) and human cells (19) via TLR2. However, M. ab-
scessus-derived proteins with TLR agonistic effects have not 
yet been identified. Here, we describe the biological activity 
and cellular immune responses of M. abscessus MAB2560 in 
DC-mediated T cell immunity and show that TLR4 signaling is 
involved in the maturation and activation of DCs stimulated by 
MAB2560.
　Several studies have reported that MAPKs, especially ERK1/2 
and p38, are key modulators of granuloma formation during 
NTM infection (20). Consistent with these reports, our result 
showed the activation of MAPKs in MAB2560-treated DCs. 
Thus, the activation of MAPKs by MAB2560 is a potent mech-
anism underlying the enhancement of IL-12 production in 
DCs. Taken together, our findings suggest that MAB2560 en-
hances DC maturation via TLR4 and elicits MAPKs-mediated 
production of IL-12. The induction of IL-12 production is then 
responsible for activating and polarizing the naïve CD4+ T 
cells toward Th1 cells that produce IFN-γ. The production of 
IFN-γ in PBMCs is represents to be severely compromised in 
patients with tuberculosis (21). In this regard, IFN-γ is critically 
important in the host defense against to M. abscessus (22). 
　In this study, MAB2560 establishes a link between the in-
nate DCs function and the adaptive Th1 immunity to M. 
abscessus. The characteristic of the bacterial pathogens that 
are encountered by the adaptive immune response tailors the 
balance of the Th1/Th2 response to a particular pathogen (23). 
Our results suggest that M. abscessus MAB2560 stimulates 
DCs and specifically produces the Th1 immunity ex vivo. The 
enhancement of IL-12 production by DCs and IFN-γ by T cells 
is strongly evaluated by MAB2560 stimulation. 
　In conclusion, MAB2560 is a potent protein that induces 
DCs maturation and Th1-mediated responses. Understanding 
the mechanism about how MAB2560 modulates the function 
of DCs may contribute to vaccine development against M. ab-
scessus infection. Further understanding of the mechanism by 
which MAB2560 regulates the DC function may aid in the de-
velopment of effective M. abscessus vaccines and an effective 
immunotherapy adjuvant for other infectious diseases. 
Moreover, identification of mycobacterial antigens as an ad-
juvant that induces the activation of APCs may affect the de-
velopment of immunotherapy in the future.
MATERIALS AND METHODS
Animals 
Female (4-6 weeks old) C57BL/6 (H-2Kb and I-Ab) mice were 
purchased from the Korean Institute of Chemistry Technology 
(Daejeon, Korea). C57BL/6 OT-I T-cell receptor (TCR) trans-
genic mice, C57BL/6 OT-II TCR transgenic mice, C57BL/6J 
TLR2-/- (B6.129-Tlr2tm1Kir/J), and C57BL/10 TLR4-/- (C57BL/ 
10ScNJ) were purchased at 6 to 8 weeks of age from The 
Jackson Laboratory (Bar Harbor, ME). All mice were housed in 
a specific pathogen-free environment and used in accordance 
with the institutional guidelines for animal care. 
Reagents and antibodies
Recombinant murine granulocyte-macrophage colony-stim-
ulating factor (rmGM-CSF) and rmIL-4 were purchased from 
R&D Systems (Minneapolis, MN). Cytokine enzyme-linked im-
munosorbent assay (ELISA) kits for murine IL-12p70, TNF-α, 
IL-10, IL-1β, and IL-6 were purchased from R&D Systems. 
Fluorescein isothiocyanate (FITC)- or phycoerythrin 
(PE)-conjugated monoclonal antibodies (mAbs) used to detect 
the expression of CD11c (HL3), CD80 (16-10A1), CD86 (GL1), 
IAb β-chain (AF-120.1), and H2Kb (AF6-88.5) by flow cy-
tometry, as well as isotype-matched control mAbs and the bio-
tinylated anti-CD11c (N418) mAb, were purchased from R&D 
Systems. Antibodies against phospho-ERK, ERK, phospho-p38, 
phospho-JNK, and tubulin were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA).
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Expression and purification of MAB2560 from E. coli
MAB2560 gene was amplified by PCR using M. abscessus ge-
nomic DNA (ATCC19977) as a template and the following pri-
mers: forward, 5'-CAT ATG ACG AGC GTT GAC GTG CCC 
TCG-3', and reverse, 5'-AAG CTT TAG GCC GGA GGG CAC 
GAC CTT-3'. The PCR product was cut with NdeI and HindIII 
and then inserted into pET28a vector cut with the same re-
striction enzymes. The recombinant plasmid was transformed 
into E. coli BL21 cells carrying bacteriophage DE3 for protein 
overexpression. Recombinant MAB2560 was produced from E. 
coli (rEC-MAB2560). Recombinant E. coli (pET22b-MAB2560) 
cells were incubated in LB medium (100 μg/ml ampicillin) at 
37oC for 12 h. Next, the cells were treated with 1 mM iso-
propyl-β-D-thio-galactoside (IPTG) and incubated at 37oC for 6 
h. The cells were lysed in lysis buffer (1 M DDT, lysozyme, 
PMSF) and sonicated. Vector control cells (pET-BL21) were 
treated in the same manner. The products from each cell was 
separated by 13.5% SDS-PAGE and visualized by Coomassie 
blue staining. Lastly, 6X His-tagged MAB2560 attached to a 
Ni-NTA column was purified using imidazole (50 and 100 
mM) and treated with Tachypleus amebocyte lysate (TAL) as-
say for eliminating the endotoxin in the fusion protein. 
Generation and culture of murine bone marrow-derived 
dendritic cells
Primary culture of DCs was performed as previously described 
(24, 25). 
Flow cytometric analysis of the expression of surface 
molecules
Flow cytometic analysis to detect the expression of CD80, 
CD86, MHC class I and MHC class II in CD11c positive cells 
were experimented according to the procedure of Park et al. 
(23).
Antigen uptake quantitation
Briefly, 2×105 cells were equilibrated at 37oC or 4oC for 45 
min and then pulsed with 1 mg/ml FITC-conjugated dextran, 
which was stopped with cold staining buffer. Washed cells 
were stained with PE-conjugated anti-CD11c and analyzed us-
ing a FACSCalibur flow cytometer. 
Cytokine assay
Murine IL-12p70, IL-10, IL-1β, IL-6, and TNF-α were measured 
using an ELISA kit according to the manufacturer’s instructions.
Western blot analysis 
Western bot analysis was experimented according to the pro-
cedure of Lee et al. (24).
Mixed lymphocyte reaction
Mixed lymphocyte reaction analysis was experimented accord-
ing to the procedure of Lee et al. (24).
Statistical analysis
All experiments were repeated at least 3 times with consistent 
results. Unless otherwise stated, data are expressed as mean ± 
SEM. Analysis of variance was used to compare experimental 
groups with control values, while comparisons between multi-
ple groups were made using Tukey’s multiple comparison tests 
(Prism 3.0 GraphPad software). A P value of less than 0.05 was 
considered to indicate statistical significance.
ACKNOWLEDGEMENTS
This work was supported by a grant from Pusan National 
University (PNU; Bio-Scientific Research Grant PNU-2008- 
101-102).
REFERENCES
1. Banchereau, J. and Steinman, R. M. (1998) Dendritic cells 
and the control of immunity. Nature 392, 245-252.
2. Janeway, C. A., Jr. and Medzhitov, R. (1998) Introduction: 
the role of innate immunity in the adaptive immune 
response. Semin. Immunol. 10, 349-350.
3. Falkinham, J. O., 3rd (2002) Nontuberculous mycobac-
teria in the environment. Clin. Chest. Med. 23, 529-551.
4. Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catan-
zaro, A., Daley, C., Gordin, F., Holland, S. M., 
Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., 
Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J., Jr. 
and Winthrop, K. (2007) An official ATS/IDSA statement: 
diagnosis, treatment, and prevention of nontuberculous 
mycobacterial diseases. Am. J. Respir. Crit. Care. Med. 
175, 367-416.
5. Horsburgh, C. R., Jr. and Selik, R. M. (1989) The epidemi-
ology of disseminated nontuberculous mycobacterial in-
fection in the acquired immunodeficiency syndrome 
(AIDS). Am. Rev. Respir. Dis. 139, 4-7.
6. Brown-Elliott, B. A. and Wallace, R. J., Jr. (2002) Clinical 
and taxonomic status of pathogenic nonpigmented or 
late-pigmenting rapidly growing mycobacteria. Clin. 
Microbiol. Rev. 15, 716-746.
7. Shin, D. M., Yang, C. S., Yuk, J. M., Lee, J. Y., Kim, K. H., 
Shin, S. J., Takahara, K., Lee, S. J. and Jo, E. K. (2008) 
Mycobacterium abscessus activates the macrophage innate 
immune response via a physical and functional interaction 
between TLR2 and dectin-1. Cell Microbiol. 10, 
1608-1621.
8. Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, 
J., Van Dyke, T. and Pulendran, B. (2003) Cutting edge: 
different Toll-like receptor agonists instruct dendritic cells 
to induce distinct Th responses via differential modulation 
of extracellular signal-regulated kinase-mitogen-activated 
protein kinase and c-Fos. J. Immunol. 171, 4984-4989.
9. Noss, E. H., Pai, R. K., Sellati, T. J., Radolf, J. D., Belisle, 
J., Golenbock, D. T., Boom, W. H. and Harding, C. V. 
(2001) Toll-like receptor 2-dependent inhibition of macro-
phage class II MHC expression and antigen processing by 
19-kDa lipoprotein of Mycobacterium tuberculosis. J. 
MAB2560 induces DC maturation via TLR4
Su Jung Lee, et al.
517http://bmbreports.org BMB Reports
Immunol. 167, 910-918.
10. Pecora, N. D., Gehring, A. J., Canaday, D. H., Boom, W. 
H. and Harding, C. V. (2006) Mycobacterium tuberculosis 
LprA is a lipoprotein agonist of TLR2 that regulates innate 
immunity and APC function. J. Immunol. 177, 422-429.
11. Gehring, A. J., Dobos, K. M., Belisle, J. T., Harding, C. V. 
and Boom, W. H. (2004) Mycobacterium tuberculosis 
LprG (Rv1411c): a novel TLR-2 ligand that inhibits human 
macrophage class II MHC antigen processing. J. Immunol. 
173, 2660-2668.
12. Quesniaux, V. J., Nicolle, D. M., Torres, D., Kremer, L., 
Guerardel, Y., Nigou, J., Puzo, G., Erard, F. and Ryffel, B. 
(2004) Toll-like receptor 2 (TLR2)-dependent-positive and 
TLR2-independent-negative regulation of proinflammatory 
cytokines by mycobacterial lipomannans. J. Immunol. 
172, 4425-4434.
13. Jones, B. W., Means, T. K., Heldwein, K. A., Keen, M. A., 
Hill, P. J., Belisle, J. T. and Fenton, M. J. (2001) Different 
Toll-like receptor agonists induce distinct macrophage 
responses. J. Leukoc. Biol. 69, 1036-1044.
14. Gilleron, M., Quesniaux, V. F. and Puzo, G. (2003) 
Acylation state of the phosphatidylinositol hexamanno-
sides from Mycobacterium bovis bacillus Calmette Guerin 
and mycobacterium tuberculosis H37Rv and its im-
plication in Toll-like receptor response. J. Biol. Chem. 
278, 29880-29889.
15. Bansal, K., Elluru, S. R., Narayana, Y., Chaturvedi, R., 
Patil, S. A., Kaveri, S. V., Bayry, J. and Balaji, K. N. (2010) 
PE_PGRS antigens of Mycobacterium tuberculosis induce 
maturation and activation of human dendritic cells. J. 
Immunol. 184, 3495-3504.
16. Jung, I. D., Jeong, S. K., Lee, C. M., Noh, K. T., Heo, D. 
R., Shin, Y. K., Yun, C. H., Koh, W. J., Akira, S., Whang, 
J., Kim, H. J., Park, W. S., Shin, S. J. and Park, Y. M. 
(2011) Enhanced efficacy of therapeutic cancer vaccines 
produced by co-treatment with Mycobacterium tuber-
culosis heparin-binding hemagglutinin, a novel TLR4 
agonist. Cancer Res. 71, 2858-2870.
17. Byun, E. H., Kim, W. S., Kim, J. S., Won, C. J., Choi, H. 
G., Kim, H. J., Cho, S. N., Lee, K., Zhang, T., Hur, G. M. 
and Shin, S. J. (2012) Mycobacterium paratuberculosis 
CobT activates dendritic cells via engagement of Toll-like 
receptor 4 resulting in Th1 cell expansion. J. Biol. Chem. 
287, 38609-38624.
18. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. 
C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M. 
and Aderem, A. (2001) The innate immune response to 
bacterial flagellin is mediated by Toll-like receptor 5. 
Nature 410, 1099-1103.
19. Sampaio, E. P., Elloumi, H. Z., Zelazny, A., Ding, L., 
Paulson, M. L., Sher, A., Bafica, A. L., Shea, Y. R. and 
Holland, S. M. (2008) Mycobacterium abscessus and M. 
avium trigger Toll-like receptor 2 and distinct cytokine re-
sponse in human cells. Am. J. Respir. Cell. Mol. Biol. 39, 
431-439.
20. Sim, Y. S., Kim, S. Y., Kim, E. J., Shin, S. J. and Koh, W. J. 
(2012) Impaired Expression of MAPK Is Associated with 
the Downregulation of TNF-alpha, IL-6, and IL-10 in 
Mycobacterium abscessus Lung Disease. Tuberc. Respir. 
Dis. (Seoul) 72, 275-283.
21. Ordway, D., Henao-Tamayo, M., Smith, E., Shanley, C., 
Harton, M., Troudt, J., Bai, X., Basaraba, R. J., Orme, I. M. 
and Chan, E. D. (2008) Animal model of Mycobacterium 
abscessus lung infection. J. Leukoc. Biol. 83, 1502-1511.
22. Vilcek, J., Klion, A., Henriksen-DeStefano, D., Zemtsov, 
A., Davidson, D. M., Davidson, M., Friedman-Kien, A. E. 
and Le, J. (1986) Defective gamma-interferon production 
in peripheral blood leukocytes of patients with acute 
tuberculosis. J. Clin. Immunol. 6, 146-151.
23. Lee, J. S., Shin, S. J., Collins, M. T., Jung, I. D., Jeong, Y. I., 
Lee, C. M., Shin, Y. K., Kim, D. and Park, Y. M. (2009) 
Mycobacterium avium subsp. paratuberculosis fibronectin 
attachment protein activates dendritic cells and induces a 
Th1 polarization. Infect. Immun. 77, 2979-2988.
24. Lee, S. J., Noh, K. T., Kang, T. H., Han, H. D., Shin, S. J., 
Soh, B. Y., Park, J. H., Shin, Y. K., Kim, H. W., Yun, C. H., 
Park, W. S., Jung, I. D. and Park, Y. M. (2014) The 
Mycobacterium avium subsp. Paratuberculosis protein 
MAP1305 modulates dendritic cell-mediated T cell pro-
liferation through Toll-like receptor-4. BMB Rep. 47, 
115-120.
25. Noh, K. T., Son, K. H., Jung, I. D., Kang, H. K., Hwang, S. 
A., Lee, W. S., You, J. C. and Park, Y. M. (2012) Protein 
kinase C delta (PKCdelta)-extracellular signal-regulated kin-
ase 1/2 (ERK1/2) signaling cascade regulates glycogen syn-
thase kinase-3 (GSK-3) inhibition-mediated interleukin-10 
(IL-10) expression in lipopolysaccharide (LPS)-induced 
endotoxemia. J. Biol. Chem. 287, 14226-14233.
